T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as the foundation for various investigational CAR-T therapies
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The company plans to expand their capacity to meet the needs of pharma and biotech industries
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The company has has 10 existing labs in India
The funds will be used to scale up existing operations and launch new products
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Subscribe To Our Newsletter & Stay Updated
